Losing Weight Program 3 Week Diet Has Become 2018's Fast Weight Loss Diet Plan For Beginners
Mar 27, 2018 01:03 am UTC| Business
SAN DIEGO, March 26, 2018 -- At a time when a majority of mainstream diets are being called “time-consuming, inefficient and just plain ineffective,” a new diet plan is drawing attention for producing very fast...
Mar 27, 2018 01:02 am UTC| Business
SAN DIEGO, March 26, 2018 -- The key to weight loss is simply a matter of “eating less and exercising more” — at least that’s what mainstream medicine wants us to believe. Personal trainer and health and nutrition coach...
Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S.
Mar 27, 2018 01:00 am UTC| Business
SINGAPORE, March 26, 2018 -- ASLAN Pharmaceuticals (ASLAN) (6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and...
CORRECTING and REPLACING - uBreakiFix Expands in Orange County, Opens in Windermere
Mar 27, 2018 00:44 am UTC| Business
WINDERMERE, Fla., March 26, 2018 -- In a release issued Thursday, March 22, 2018, under the same headline, uBreakiFix provided an incorrect phone number in the ninth paragraph. The correct number is (407) 777-4410,...
How To Lose Weight Fast and Easy with Brian Flatt's New 3 Week Easy To Follow Diet Plan
Mar 27, 2018 00:21 am UTC| Business
SAN DIEGO, March 26, 2018 -- There’s a simple reason why most diets fail — they do not produce results fast enough. ...
Toscana Energy Announces Internalization of Management Agreement
Mar 27, 2018 00:17 am UTC| Business
CALGARY, Alberta, March 26, 2018 -- Toscana Energy Income Corporation ("Toscana" or the "Corporation") (TSX:TEI) announces that it has entered into an agreement with Toscana Energy Corporation (“TEC”), a member of the...
Hua Medicine Raises $117.4 Million in Series D & Series E Financing
Mar 27, 2018 00:00 am UTC| Business
HONG KONG and SHANGHAI, China, March 26, 2018 -- Hua Medicine, a clinical-stage drug development company developing novel therapies for the treatment of Type 2 diabetes, announced the closing of a combined Series D ...